Cequenet Pharmaceuticals just received $9M in Series A financing from the Novartis Option Fund. They plan to spend their new found money on Product Development. They recently hired a new Clinical Development Director. Cequenet is a early stage therapeutics company that treats diseases including cancer.
Cequent Pharmaceuticals Profile
Cequent Pharma Website
Abonohu te:
Posto komente (Atom)
Nuk ka komente:
Posto një koment